Thousands could benefit from leukaemia drug banned for patients given all-clear after NHS U-turn  

NHS England previously limited Ibrutinib so patients who had been in remission for more than three years missed out. The once-daily pill works by inhibiting the growth of cancerous cells.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news